Search research articles
Contact Us
Filters
Showing results (141-150 of 428) with videos related to
Page
of 43
Sort By:
The New England Journal of Medicine
|
November 7, 1974
Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma
N Jaffe, E Frei, D Traggis, et al.
Cancer Letters
|
December 9, 1994
Long-term persistence and cytokinetics of human tumor cells in vitro following high-dose alkylating agent exposure
S A Holden, B A Teicher, E Frei
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|
December 18, 1990
[Laparoscopic cholecystectomy--results in the initial 100 cases]
E Frei, J Middendorp, C Klaiber, et al.
Journal of Cancer Research and Clinical Oncology
|
November 17, 2001
Human cervical tumor cell (SiHa) surface alphavbeta3 integrin receptor has associated matrix metalloproteinase (MMP-2) activity
N Chattopadhyay, A Mitra, E Frei, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Postlabeling detection of DNA adducts of antitumor alkylating agents
G H Zhou, B A Teicher, E Frei
Important Advances in Oncology
|
January 1, 1987
Induction chemotherapy as initial treatment for advanced head and neck cancer: a model for the multidisciplinary treatment of solid tumors
J R Clark, B G Fallon, E Frei
Cancer Chemotherapy Reports
|
June 1, 1971
Dose-schedule studies with hydroxyurea (NSC-32065) in malignant melanoma
J A Gottlieb, E Frei, J K Luce
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|
October 20, 1987
[Painful knee, fever]
D Moradpour, M Flepp, E Frei, et al.
International Journal of Cancer
|
March 1, 1996
High-dose therapy/stem cell support: comparison of mice and humans
B A Teicher, D Northey, J Yuan, et al.
Carcinogenesis
|
May 1, 1997
Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases
H H Schmeiser, E Frei, M Wiessler, et al.
Page
of 43
Search research articles
Search
Showing results (141-150 of 428) with videos related to
Sort By:
Page
of 43
The New England Journal of Medicine
|
November 7, 1974
Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma
N Jaffe, E Frei, D Traggis, et al.
Cancer Letters
|
December 9, 1994
Long-term persistence and cytokinetics of human tumor cells in vitro following high-dose alkylating agent exposure
S A Holden, B A Teicher, E Frei
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|
December 18, 1990
[Laparoscopic cholecystectomy--results in the initial 100 cases]
E Frei, J Middendorp, C Klaiber, et al.
Journal of Cancer Research and Clinical Oncology
|
November 17, 2001
Human cervical tumor cell (SiHa) surface alphavbeta3 integrin receptor has associated matrix metalloproteinase (MMP-2) activity
N Chattopadhyay, A Mitra, E Frei, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Postlabeling detection of DNA adducts of antitumor alkylating agents
G H Zhou, B A Teicher, E Frei
Important Advances in Oncology
|
January 1, 1987
Induction chemotherapy as initial treatment for advanced head and neck cancer: a model for the multidisciplinary treatment of solid tumors
J R Clark, B G Fallon, E Frei
Cancer Chemotherapy Reports
|
June 1, 1971
Dose-schedule studies with hydroxyurea (NSC-32065) in malignant melanoma
J A Gottlieb, E Frei, J K Luce
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|
October 20, 1987
[Painful knee, fever]
D Moradpour, M Flepp, E Frei, et al.
International Journal of Cancer
|
March 1, 1996
High-dose therapy/stem cell support: comparison of mice and humans
B A Teicher, D Northey, J Yuan, et al.
Carcinogenesis
|
May 1, 1997
Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases
H H Schmeiser, E Frei, M Wiessler, et al.
Page
of 43